Page 4 - Pathogen Panel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article Share this article AUSTIN, Texas, March 4, 2021 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for a new expanded version of its NxTAG ® Respiratory Pathogen Panel (RPP) that includes the SARS-CoV-2 virus for high-throughput respiratory testing. The new test is a combination of the company's original NxTAG RPP, an FDA-cleared in vitro diagnostic for syndromic respiratory infection testing, and SARS-CoV-2. Respiratory infections such as COVID-19 and i...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ProPhase Labs Announces Opening of Large CLIA Lab Covid Testing Facility in Garden City, New York ProPhase Labs, Inc.January 29, 2021 GMT - Total Company Processing Capacity On Track to Reach 60,000 Tests Per Day – GARDEN CITY, NY, Jan. 29, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, announced today the opening of its 25,000 square foot facility in Garden City, New York. The new lab features state-of-the-art technology and offe...

ProPhase Labs, Inc. Announces Closing of Public Offering January 21, 2021 16:30 ET | Source: ProPhase Labs, Inc. ProPhase Labs, Inc. DOYLESTOWN, Pennsylvania, UNITED STATES Garden City, NY, Jan. 21, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, today announced the closing of its previously announced public offering of 3,000,000 shares of its common stock at a public offering price of $12.50 per share, for gross proceeds of $37,500,000, before deducting underwriting discounts and ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.